发明名称 Substituted 2 amino imidazoles, method for their manufacture and their use as a drug or diagnostic and drug containing them
摘要 <p>2-Anilinoimidazoles (I) are new. 2-Anilinoimidazoles of formula (I) and their salts are new: [Image] R 1, R 2H, 1-4C (fluoro)alkyl, CN or phenyl or form a 5- to 8-membered carbocyclic ring with 1-2 double bonds, optionally substituted with 1-12 F atoms or with 1-2 of OH, NR 8R 9, 1-4C alkyl, CN, CF 3or 1-4C alkoxy, provided that R 1and R 2are not both H; R 9, R 10H or 1-4C alkyl; R 3-R 7H, halo, 1-4C (fluoro)alkyl or 1-4C (fluoro)alkoxy, provided than R 3and R 7are not both H; R 8H, 1-4C (fluoro)alkyl or 3-5C (fluoro)cycloalkyl; provided that R1 and R2 are not both Me when R 3is Cl and R 4-R 8are H. An independent claim is also included for production of alpha -amino ketals of formula (V) by reacting an alpha -halo ketone or aldehyde of formula (VI) with an azide, reacting the resulting alpha -azido ketone or aldehyde with a mono- or dihydric alcohol to form a ketal or acetal of formula (VIII) and reducing this to (V). [Image] R 1, R 2H, 1-6C alkyl, 2-6C alkenyl, 2-6C alkynyl, 3-6C cycloalkyl, 4-6C cycloalkenyl or phenyl, where phenyl is optionally substituted with 1-2 of halo, NR 11R 12, 1-4C alkyl, CN, CF 3or 1-4C alkoxy and carbon chains are optionally substituted with 1-9 F atoms or 1-2 of NR 11R 12, 1-4C alkyl, CN, CF 3or 1-4C alkoxy, or R 1+R 2forms a 5- to 8-membered carbocyclic ring with 1-2 double bonds, optionally substituted with 1-12 F atoms or with 1-2 of OH, NR 11R 12, 1-4C alkyl, CN, CF 3or 1-4C alkoxy; R 11, R 121-4C alkyl, benzyl or 4-methoxybenzyl; E : 1-4C alkyl or E+E is 2-4C alkylene. ACTIVITY : Nephrotropic; Laxative; Hypotensive; Anticonvulsant; Tranquilizer; Antidepressant; Neuroleptic; Cerebroprotective; Vasotropic; Antiarteriosclerotic; Antilipemic; Anticoagulant; Antiparasitic; Protozoacide; Antidiabetic; Cytostatic. MECHANISM OF ACTION : Sodium/hydrogen exchanger inhibitor. N-(2,6-dichorophenyl)-N-(4-methyl-1H-imidazol-2-yl)amine hydrochloride had an IC 50of 1.7 MicroM against intracellular pH restoration by recombinant sodium/hydrogen exchanger 3 in LAP1 fibroblasts.</p>
申请公布号 EP1857445(A2) 申请公布日期 2007.11.21
申请号 EP20070014956 申请日期 2004.01.20
申请人 SANOFI-AVENTIS DEUTSCHLAND GMBH 发明人 HEINELT, UWE, DR.;LANG, HANS-JOCHEN, DR.;HOFMEISTER, ARMIN, DR.;WIRTH, KLAUS, DR.;JANSEN, HANS-WILLI, DR.
分类号 C07D233/50;A61K31/4164;A61K31/4168;A61P1/10;A61P9/12;A61P11/16;A61P13/12;A61P33/02;A61P39/00;C07D233/66;C07D235/30 主分类号 C07D233/50
代理机构 代理人
主权项
地址